{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:41:22Z","timestamp":1787319682185,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Paediatric Respiratory Reviews"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.prrv.2024.09.002","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T13:44:41Z","timestamp":1729604681000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Addition of long\u2010acting beta\u2010agonists to inhaled corticosteroids for asthma in preschool children: A systematic review"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3706-0210","authenticated-orcid":false,"given":"Dominika","family":"Ambro\u017cej","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9377-132X","authenticated-orcid":false,"given":"Maja","family":"Cie\u015blik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6613-2012","authenticated-orcid":false,"given":"Wojciech","family":"Feleszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2560-6693","authenticated-orcid":false,"given":"Carlos E.","family":"Rodriguez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0708-4281","authenticated-orcid":false,"given":"Jose A.","family":"Castro-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prrv.2024.09.002_b0005","first-page":"53","article-title":"a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents","volume":"2019","author":"Reddel","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2024.09.002_b0010","unstructured":"Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma. 2023."},{"issue":"146","key":"10.1016\/j.prrv.2024.09.002_b0015","first-page":"1217","article-title":"Focused updates to the asthma management guidelines: a report from the national asthma education and prevention program coordinating committee expert panel working group","volume":"2020","author":"Expert Panel Working Group of the National Heart, Lung, and Blood Institute (NHLBI) administered and coordinated National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC) MM","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.prrv.2024.09.002_b0020","doi-asserted-by":"crossref","unstructured":"Corrigenda. J Allergy Clin Immunol 2021;147:1528\u201330. https:\/\/doi.org\/10.1016\/j.jaci.2021.02.010.","DOI":"10.1016\/j.jaci.2021.02.010"},{"key":"10.1016\/j.prrv.2024.09.002_b0025","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00431-017-2936-6","article-title":"A meta-analysis of montelukast for recurrent wheeze in preschool children","volume":"176","author":"Hussein","year":"2017","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.prrv.2024.09.002_b0030","first-page":"CD008202","article-title":"Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children","volume":"2015","author":"Brodlie","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prrv.2024.09.002_b0035","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/ppul.24176","article-title":"Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: A systematic review","volume":"53","author":"Castro-Rodriguez","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2024.09.002_b0040","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-4496","article-title":"Preventing exacerbations in preschoolers with recurrent wheeze: a meta-analysis","volume":"137","author":"Kaiser","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.prrv.2024.09.002_b0045","doi-asserted-by":"crossref","first-page":"e1003583","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"18","author":"Page","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.prrv.2024.09.002_b0050","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.prrv.2024.09.002_b0055","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.prrv.2024.09.002_b0060","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1081\/JAS-120033986","article-title":"Efficacy and safety of inhaled corticosteroids in combination with a long-acting beta2-agonist in asthmatic children under age 5","volume":"41","author":"Sekhsaria","year":"2004","journal-title":"J Asthma"},{"key":"10.1016\/j.prrv.2024.09.002_b0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.anai.2012.05.006","article-title":"Salmeterol and fluticasone in young children with multiple-trigger wheeze","volume":"109","author":"M\u00e4kel\u00e4","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.prrv.2024.09.002_b0070","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-0042-108852","article-title":"Efficacy and safety of salmeterol\/fluticasone combination therapy in infants and preschool children with asthma insufficiently controlled by inhaled corticosteroids","volume":"66","author":"Yoshihara","year":"2016","journal-title":"Drug Res (Stuttg)"},{"key":"10.1016\/j.prrv.2024.09.002_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.562843","article-title":"Hospitalization, asthma phenotypes, and readmission rates in pre-school asthma","volume":"8","author":"Donath","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.prrv.2024.09.002_b0080","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/02770903.2018.1474923","article-title":"Efficacy and safety of the combination fluticasone propionate plus salmeterol in asthmatic preschoolers: An observational study","volume":"56","author":"Hatziagorou","year":"2019","journal-title":"J Asthma"},{"key":"10.1016\/j.prrv.2024.09.002_b0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/pai.13010","article-title":"The efficacy and safety of fluticasone\/salmeterol compared to fluticasone in children younger than four years of age","volume":"30","author":"Yoshihara","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.prrv.2024.09.002_b0090","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/ped.2020.1196","article-title":"Comparison of two therapies on asthma control in children","volume":"33","author":"Al-Turki","year":"2020","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"10.1016\/j.prrv.2024.09.002_b0095","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1378\/chest.130.6.1733","article-title":"Budesonide\/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma","volume":"130","author":"Bisgaard","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.prrv.2024.09.002_b0100","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1399-3038.2009.00861.x","article-title":"Salmeterol\/fluticasone propionate vs. double dose fluticasone propionate on lung function and asthma control in children","volume":"20","author":"de Blic","year":"2009","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.prrv.2024.09.002_b0105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1081-1206(10)61190-8","article-title":"The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma","volume":"95","author":"Malone","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.prrv.2024.09.002_b0110","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2500\/aap.2010.31.3362","article-title":"Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma","volume":"31","author":"Murray","year":"2010","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.prrv.2024.09.002_b0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12931-016-0353-4","article-title":"Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy","volume":"17","author":"Oliver","year":"2016","journal-title":"Respir Res"},{"key":"10.1016\/j.prrv.2024.09.002_b0120","doi-asserted-by":"crossref","DOI":"10.1177\/1753466618777924","article-title":"Efficacy and safety of fluticasone propionate\/formoterol fumarate in pediatric asthma patients: a randomized controlled trial","volume":"12","author":"P\u0142oszczuk","year":"2018","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.prrv.2024.09.002_b0125","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1399-3038.2006.00425.x","article-title":"Budesonide\/formoterol improves lung function compared with budesonide alone in children with asthma","volume":"17","author":"Pohunek","year":"2006","journal-title":"Pediatr Allergy Immunol"},{"issue":"5","key":"10.1016\/j.prrv.2024.09.002_b0130","first-page":"423","article-title":"Salmeterol xinafoate in children on high dose inhaled steroids","volume":"75","author":"Russell","year":"1995","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.prrv.2024.09.002_b0135","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ppul.10173","article-title":"Budesonide\/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma","volume":"34","author":"Tal","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2024.09.002_b0140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/1099-0496(200008)30:2<97::AID-PPUL4>3.0.CO;2-P","article-title":"Salmeterol\/fluticasone propionate (50\/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma","volume":"30","author":"Van den Berg","year":"2000","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2024.09.002_b0145","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa1905560","article-title":"Step-Up therapy in black children and adults with poorly controlled asthma","volume":"381","author":"Wechsler","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prrv.2024.09.002_b0150","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/ppul.24667","article-title":"A phase 3 study evaluating the safety and efficacy of a pediatric dose of mometasone furoate with and without formoterol for persistent asthma","volume":"55","author":"Weinstein","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2024.09.002_b0155","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/ppul.21120","article-title":"Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED)","volume":"44","author":"Gappa","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2024.09.002_b0160","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1164\/rccm.200407-884OC","article-title":"Budesonide\/formoterol combination therapy as both maintenance and reliever medication in asthma","volume":"171","author":"O\u2019Byrne","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2024.09.002_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2024.06.024","article-title":"Once-Daily fluticasone furoate\/vilanterol versus once-daily fluticasone furoate in asthma patients aged 5\u201317 years","author":"Bareille","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.prrv.2024.09.002_b0170","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00701-2020","article-title":"ICS-formoterol reliever versus ICS and short-acting \u03b22-agonist reliever in asthma: a systematic review and meta-analysis","volume":"7","author":"Hatter","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.prrv.2024.09.002_b0175","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01688-2017","article-title":"Budesonide\/formoterol maintenance and reliever therapy in adolescent patients with asthma","volume":"51","author":"Jorup","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2024.09.002_b0180","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1016\/j.jaip.2021.08.033","article-title":"Reply to \u201cAs-needed budesonide-formoterol for adolescents with mild asthma: importance of lung function\u201d","volume":"9","author":"Reddel","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.prrv.2024.09.002_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12237270","article-title":"On-Demand ICS + FABA Combinations in 6\u201311-Year-Old Children","volume":"12","author":"Navarrete-Rodr\u00edguez","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.prrv.2024.09.002_b0190","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1164\/ajrccm\/146.4.888","article-title":"A community-based study of the epidemiology of asthma. Incidence Rates, 1964-1983","volume":"146","author":"Yunginger","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.prrv.2024.09.002_b0195","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/thx.2005.055699","article-title":"A 10 year asthma programme in Finland: major change for the better","volume":"61","author":"Haahtela","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.prrv.2024.09.002_b0200","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.200504-525OC","article-title":"Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence","volume":"172","author":"Morgan","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2024.09.002_b0205","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(08)61447-6","article-title":"Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study","volume":"372","author":"Stern","year":"2008","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.prrv.2024.09.002_b0210","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1164\/rccm.201608-1561LE","article-title":"Low lung function in young adult life is associated with early mortality","volume":"195","author":"Vasquez","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2024.09.002_b0215","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1183\/09031936.02.00258502","article-title":"Age-related differences in perceived asthma control in childhood: guidelines and reality","volume":"20","author":"Kuehni","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2024.09.002_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.05.012","article-title":"Trends in the age of diagnosis of childhood asthma","volume":"134","author":"Radhakrishnan","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.prrv.2024.09.002_b0225","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1080\/02770903.2021.1934696","article-title":"Children with under-diagnosed asthma presenting to a pediatric emergency department","volume":"59","author":"Pade","year":"2022","journal-title":"J Asthma"},{"key":"10.1016\/j.prrv.2024.09.002_b0230","doi-asserted-by":"crossref","first-page":"47","DOI":"10.15586\/aei.v49i4.100","article-title":"Hospital admission for symptoms exacerbation in 2,075 infants suffering from recurrent asthma-like symptoms: (EISL-3 South America)","volume":"49","author":"Mallol","year":"2021","journal-title":"Allergol Immunopathol (Madr)"}],"container-title":["Paediatric Respiratory Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054224000794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054224000794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T21:59:15Z","timestamp":1756936755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526054224000794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":46,"alternative-id":["S1526054224000794"],"URL":"https:\/\/doi.org\/10.1016\/j.prrv.2024.09.002","relation":{},"ISSN":["1526-0542"],"issn-type":[{"value":"1526-0542","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addition of long\u2010acting beta\u2010agonists to inhaled corticosteroids for asthma in preschool children: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Paediatric Respiratory Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prrv.2024.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}